Skip to content
OpenCapital
Get started

Danaher DHR Life Sciences — Segment Reporting, Other Segment Item, Amount

Other segment segments

Diagnostics
$1.86B+15.9%
Biotechnology
$1.09B+3.8%

Similar metrics at other companies

CryoPort, Inc. logo
CYRXLife Sciences Products — Segment Reporting Other Item Amount
$1.48M+34.2%
CryoPort, Inc. logo
CYRXLife Sciences Services — Segment Reporting Other Item Amount
$4.04M+17.4%
PTC Therapeutics logo
PTCTLife Science — Segment Reporting Other Item Amount
$107.89M-25.8%
Donaldson Company logo
DCILife Sciences Segment — Other segment items
$27.5M+20.6%
Thermo Fisher Scientific logo
TMOLife Sciences Solutions — Other segment items
$50M+11.1%
GLW
GLWLife Sciences and Emerging Growth Businesses — Other segment items
$249M-1.2%

Other financials

Income statement

See full
Revenue$6.3B+5.5%
Gross profit$3.6B+2.5%
Operating income$1.1B+48.3%
Net income$870.0M+56.8%
EPS (diluted)$1.23+59.7%

Balance sheet

See full
Cash & equivalents$4.3B+47.0%
Total debt$27.9B+50.1%
Total equity$52.6B+0.5%
Total assets$92.4B+13.2%

Cash flow

See full
Operating cash flow$1.5B+14.6%
CapEx$269.0M+8.5%
Free cash flow$1.3B+16.1%

Valuation

See full
Market cap$134.62B-7.4%
Enterprise value$158.13B-1.7%
P/E33.6×-9.0×
P/S5.4×-0.7×

Profitability

See full
Gross margin58.5%-1.1pp
Operating margin20.4%+2.0pp
Net margin15.9%+1.7pp
FCF margin21.8%+1.5pp

Returns & leverage

See full
Return on equity7.6%+1.0pp
Debt / equity0.5×+0.2×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Danaher in its filing.

Tagged under the XBRL concept us-gaap:SegmentReportingOtherItemAmount.

The official record: Danaher’s 10-Q, filed July 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about Danaher's life sciences — segment reporting, other segment item, amount.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Danaher's life sciences — segment reporting, other segment item, amount?
Danaher (DHR) reported life sciences — segment reporting, other segment item, amount of $1.44B in Q2 2026.
How has Danaher's life sciences — segment reporting, other segment item, amount changed year-over-year?
Danaher's life sciences — segment reporting, other segment item, amount increased by 3.4% year-over-year, from $1.39B to $1.44B.
What is the long-term trend for Danaher's life sciences — segment reporting, other segment item, amount?
Over 3 years (2022 to 2025), Danaher's life sciences — segment reporting, other segment item, amount has grown at a 3.1% compound annual growth rate (CAGR), from $5.09B to $5.58B.
What does life sciences — segment reporting, other segment item, amount mean?
Represents miscellaneous operational costs or adjustments specific to the Life Sciences segment that do not fall into standard categories like COGS or SG&A. This may include restructuring costs, integration expenses, or other non-recurring operational items. It provides transparency into the 'noise' affecting the segment's core operating performance.